Louisiana State Employees Retirement System’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,700
Closed -$211K 1517
2024
Q3
$211K Sell
9,700
-500
-5% -$11.2K ﹤0.01% 1515
2024
Q2
$200K Buy
10,200
+200
+2% +$4.17K ﹤0.01% 1510
2024
Q1
$217K Sell
10,000
-100
-1% -$2.48K ﹤0.01% 1505
2023
Q4
$292K Sell
10,100
-300
-3% -$8.03K 0.01% 1482
2023
Q3
$278K Hold
10,400
0.01% 1462
2023
Q2
$385K Buy
10,400
+1,200
+13% +$41.8K 0.01% 1388
2023
Q1
$287K Sell
9,200
-200
-2% -$6.44K 0.01% 1413
2022
Q4
$280K Sell
9,400
-300
-3% -$10.7K 0.01% 1410
2022
Q3
$370K Buy
9,700
+200
+2% +$10K 0.01% 1316
2022
Q2
$561K Buy
9,500
+100
+1% +$5.5K 0.02% 1186
2022
Q1
$561K Hold
9,400
0.01% 1273
2021
Q4
$946K Buy
9,400
+200
+2% +$17.6K 0.02% 970
2021
Q3
$828K Buy
9,200
+1,200
+15% +$109K 0.02% 1018
2021
Q2
$738K Hold
8,000
0.02% 1092
2021
Q1
$773K Buy
8,000
+2,000
+33% +$206K 0.02% 1041
2020
Q4
$313K Buy
6,000
+500
+9% +$20.9K 0.01% 1364
2020
Q3
$220K Buy
+5,500
New +$172K 0.01% 1343

Other funds holding FLGT

Louisiana State Employees Retirement System's FLGT Position: Q4 2024 in Review

Louisiana State Employees Retirement System sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 9,700 shares — an estimated $211K sold.

Louisiana State Employees Retirement System first reported a position in FLGT in Q3 2020 and held it in 17 quarters. The position peaked at $946K in Q4 2021. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Louisiana State Employees Retirement System reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Louisiana State Employees Retirement System sold 9,700 Fulgent Genetics shares in Q4 2024, an estimated $211K.
  • Louisiana State Employees Retirement System first reported a position in Fulgent Genetics in Q3 2020 and held it in 17 quarters.
  • Louisiana State Employees Retirement System's Fulgent Genetics position peaked at $946K in Q4 2021.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Louisiana State Employees Retirement System's 13F filing for Q4 2024, filed 29 Jan 2025.